- call +1-201-465-4211
- email sales@mrinsights.biz
Chondrosarcoma refers to cancer of cartilage, a flexible connective tissue found in joints between bones, the ear, the rib cage etc. According to Cancer Network Journal, chondrosarcoma contributes to almost half of the osteosarcoma cases and is the second most common type of osteosacrcoma (tumor of bones). Chondrosarcoma can start at any age but most commonly found in adults above the age of 20 years. As per the statistics of American Cancer Society, occurrence of chondrosarcoma in patients younger than 20 years is less than 5%. Chondrosarcoma mainly affects the cartilage of arms, ribs, pelvis, and scapula and rarely found in trachea, breast and other parts of the body showing presence of cartilage tissue. Chondrosarcoma patients do not show any symptoms at an early stage hence, it can only be diagnosed in the late stage of a tumor when it shows fracture and bony bump at the tumor site. Diagnosis of chondrosarcoma can be done using radiography (X-Ray), computerized tomography (CT scan) or magnetic resonance imaging (MRI). Unlike other cancers chondrosarcoma is resistant to chemotherapy and radiation therapy and can primarily be treated with surgery. Surgical procedures for chondrosarcoma treatment involve limb sparing operations, complete surgical ablation and amputation in certain cases.
Scope of the Report:
This report studies the Chondrosarcoma Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chondrosarcoma Treatment market by product type and applications/end industries.
Increasing prevalence of osteosarcoma can ultimately influence the growth of global chondrosarcoma treatment market. According to Cancer Network Journal the incidence of osteosacrcoma in the U.S. is approximately 800 cases per year. Other factors responsible for growth of global chondrosarcoma treatment market include growing prevalence of genetic diseases.
The global Chondrosarcoma Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chondrosarcoma Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Hoffmann-La Roche
AEterna Zentaris
Acorn Research
Agios Pharmaceuticals
Infinity Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Surgical Treatment
Chemotherapy
Radiation Therapy
Market Segment by Applications, can be divided into
Hospitals
Multispecialty Clinics
Cancer Treatment Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Chondrosarcoma Treatment Market Overview
1.1 Product Overview and Scope of Chondrosarcoma Treatment
1.2 Classification of Chondrosarcoma Treatment by Types
1.2.1 Global Chondrosarcoma Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Chondrosarcoma Treatment Revenue Market Share by Types in 2017
1.2.3 Surgical Treatment
1.2.4 Chemotherapy
1.2.5 Radiation Therapy
1.3 Global Chondrosarcoma Treatment Market by Application
1.3.1 Global Chondrosarcoma Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Multispecialty Clinics
1.3.4 Cancer Treatment Centers
1.4 Global Chondrosarcoma Treatment Market by Regions
1.4.1 Global Chondrosarcoma Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Chondrosarcoma Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chondrosarcoma Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chondrosarcoma Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Chondrosarcoma Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chondrosarcoma Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Chondrosarcoma Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Hoffmann-La Roche
2.1.1 Business Overview
2.1.2 Chondrosarcoma Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hoffmann-La Roche Chondrosarcoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 AEterna Zentaris
2.2.1 Business Overview
2.2.2 Chondrosarcoma Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AEterna Zentaris Chondrosarcoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Acorn Research
2.3.1 Business Overview
2.3.2 Chondrosarcoma Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Acorn Research Chondrosarcoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Agios Pharmaceuticals
2.4.1 Business Overview
2.4.2 Chondrosarcoma Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Agios Pharmaceuticals Chondrosarcoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Infinity Pharmaceuticals
2.5.1 Business Overview
2.5.2 Chondrosarcoma Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Infinity Pharmaceuticals Chondrosarcoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Chondrosarcoma Treatment Market Competition, by Players
3.1 Global Chondrosarcoma Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Chondrosarcoma Treatment Players Market Share
3.2.2 Top 10 Chondrosarcoma Treatment Players Market Share
3.3 Market Competition Trend
4 Global Chondrosarcoma Treatment Market Size by Regions
4.1 Global Chondrosarcoma Treatment Revenue and Market Share by Regions
4.2 North America Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
5 North America Chondrosarcoma Treatment Revenue by Countries
5.1 North America Chondrosarcoma Treatment Revenue by Countries (2013-2018)
5.2 USA Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
6 Europe Chondrosarcoma Treatment Revenue by Countries
6.1 Europe Chondrosarcoma Treatment Revenue by Countries (2013-2018)
6.2 Germany Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
6.4 France Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Chondrosarcoma Treatment Revenue by Countries
7.1 Asia-Pacific Chondrosarcoma Treatment Revenue by Countries (2013-2018)
7.2 China Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
7.5 India Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
8 South America Chondrosarcoma Treatment Revenue by Countries
8.1 South America Chondrosarcoma Treatment Revenue by Countries (2013-2018)
8.2 Brazil Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Chondrosarcoma Treatment by Countries
9.1 Middle East and Africa Chondrosarcoma Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Chondrosarcoma Treatment Revenue and Growth Rate (2013-2018)
10 Global Chondrosarcoma Treatment Market Segment by Type
10.1 Global Chondrosarcoma Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Chondrosarcoma Treatment Market Forecast by Type (2018-2023)
10.3 Surgical Treatment Revenue Growth Rate (2013-2023)
10.4 Chemotherapy Revenue Growth Rate (2013-2023)
10.5 Radiation Therapy Revenue Growth Rate (2013-2023)
11 Global Chondrosarcoma Treatment Market Segment by Application
11.1 Global Chondrosarcoma Treatment Revenue Market Share by Application (2013-2018)
11.2 Chondrosarcoma Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Multispecialty Clinics Revenue Growth (2013-2018)
11.5 Cancer Treatment Centers Revenue Growth (2013-2018)
12 Global Chondrosarcoma Treatment Market Size Forecast (2018-2023)
12.1 Global Chondrosarcoma Treatment Market Size Forecast (2018-2023)
12.2 Global Chondrosarcoma Treatment Market Forecast by Regions (2018-2023)
12.3 North America Chondrosarcoma Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Chondrosarcoma Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Chondrosarcoma Treatment Revenue Market Forecast (2018-2023)
12.6 South America Chondrosarcoma Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Chondrosarcoma Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Chondrosarcoma Treatment Picture
Table Product Specifications of Chondrosarcoma Treatment
Table Global Chondrosarcoma Treatment and Revenue (Million USD) Market Spli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
